Correlation Between Champions Oncology and Kymera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and Kymera Therapeutics, you can compare the effects of market volatilities on Champions Oncology and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and Kymera Therapeutics.

Diversification Opportunities for Champions Oncology and Kymera Therapeutics

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Champions and Kymera is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and Kymera Therapeutics go up and down completely randomly.

Pair Corralation between Champions Oncology and Kymera Therapeutics

Given the investment horizon of 90 days Champions Oncology is expected to generate 1.14 times more return on investment than Kymera Therapeutics. However, Champions Oncology is 1.14 times more volatile than Kymera Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  398.00  in Champions Oncology on August 28, 2024 and sell it today you would earn a total of  20.00  from holding Champions Oncology or generate 5.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Champions Oncology  vs.  Kymera Therapeutics

 Performance 
       Timeline  
Champions Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Champions Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Champions Oncology is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Kymera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Kymera Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Champions Oncology and Kymera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Champions Oncology and Kymera Therapeutics

The main advantage of trading using opposite Champions Oncology and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.
The idea behind Champions Oncology and Kymera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.